06 Jul 2017

Anti-malaria tablets: one brand of atovaquone/proguanil to be available to purchase without prescription

A brand of anti-malaria tablet, previously available by prescription only, will shortly be available from pharmacies as an Over the Counter (OTC) medicine Anti-malaria tablets: one brand of atovaquone/proguanil to be available to purchase without prescription

Atovaquone/proguanil, a combination tablet that can be taken to prevent malaria, is currently available in branded and non-branded forms.

Following a public consultation process [1], the Medicines and Healthcare products Regulatory Agency has announced one named brand of atovaquone/proguanil as approved as an Over the Counter (OTC) medicine. This medicine will shortly be available through pharmacies without prescription and will be available to adults aged over 18, weighing more than 40kg, travelling to areas affected by malaria and where the malaria parasite is not resistant to the product ingredients [2].

Health professionals are reminded that pre-travel risk assessment is essential to tailor advice for an individual, including advice about malaria risk and options for medicine to prevent malaria.

Measles reminder

Ensure all travellers are up to date with measles vaccination Read more

Yellow fever outbreak Brazil: São Paulo State/City revised

Human and monkey cases in São Paulo State and municipalities are a public health concern Read more

NaTHNaC Annual Report 2016 to 2017

NaTHNaC publishes Annual Report Read more

WHO publishes World Malaria Report 2017

On 29 November 2017 World Health Organization (WHO) publishes the World Malaria Report 2017 Read more

Nigeria: yellow fever outbreaks

Suspected and confirmed cases of yellow fever reported to the World Health Organization Read more
Back to Top

VIEW FULL INDEX